Related Experiment Video

Updated: Apr 15, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.4K

Hypertensive Cardiomyopathy in asymptomatic patients: a neglected diagnosis

Pasquale Palmiero1, Maria Maiello, Annapaola Zito

  • 1Pasquale Palmiero, MD, 72100, Brindisi, Italy, via Francia 47. pasqualepalmiero@yahoo.it.

Current Hypertension Reviews
|March 25, 2015
PubMed

Insights

Hypertensive cardiomyopathy involves left ventricular changes in asymptomatic patients. Understanding its development in hypertension is key to preventing cardiovascular events.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Cardiovascular Disease

Background:

  • Hypertensive cardiomyopathy (HCM) encompasses diverse clinical conditions in hypertensive patients.
  • Diagnosis involves assessing left ventricular (LV) changes in geometry, mass, and function, including concentric remodeling, hypertrophy, and diastolic dysfunction.
  • Left atrial (LA) involvement, with volume increase and geometric remodeling, is common.

Purpose of the Study:

  • To elucidate the mechanisms driving the development of hypertensive cardiomyopathy.
  • To identify factors influencing the progression from hypertension to HCM.
  • To enhance the prevention of cardiovascular events in hypertensive individuals.

Main Methods:

  • Clinical assessment of asymptomatic patients with hypertension.
  • Evaluation of left ventricular (LV) geometry, mass, and function.
  • Analysis of left atrial (LA) size and geometry.
  • Consideration of pressure/volume load and neurohormonal status.
  • Exploration of potential genetic influences on LV geometry.

Main Results:

  • HCM presents with varied LV geometric patterns (remodeling, concentric/eccentric hypertrophy) and diastolic dysfunction.
  • Patients may develop symptomatic heart failure with preserved or reduced ejection fraction.
  • Significant variability exists in HCM progression, influenced by load, neurohormonal factors, and likely genetics.

Conclusions:

  • A comprehensive understanding of HCM development mechanisms is crucial.
  • Targeted interventions based on HCM pathophysiology can aid in preventing cardiovascular events.
  • Further research into genetic predispositions may refine risk stratification and prevention strategies.

More Related Videos

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

10.8K
An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

6.3K

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
793
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
711
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
856
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
773
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
803
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
909